Z. Gungor Et Al. , "Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk," ATHEROSCLEROSIS , vol.223, no.1, pp.230-234, 2012
Gungor, Z. Et Al. 2012. Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. ATHEROSCLEROSIS , vol.223, no.1 , 230-234.
Gungor, Z., Anuurad, E., Enkhmaa, B., Zhang, W., Kim, K., & Berglund, L., (2012). Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. ATHEROSCLEROSIS , vol.223, no.1, 230-234.
Gungor, Zeynep Et Al. "Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk," ATHEROSCLEROSIS , vol.223, no.1, 230-234, 2012
Gungor, Zeynep Et Al. "Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk." ATHEROSCLEROSIS , vol.223, no.1, pp.230-234, 2012
Gungor, Z. Et Al. (2012) . "Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk." ATHEROSCLEROSIS , vol.223, no.1, pp.230-234.
@article{article, author={Zeynep Gungor Et Al. }, title={Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk}, journal={ATHEROSCLEROSIS}, year=2012, pages={230-234} }